EDSA · Edesa Biotech Inc
United States · RS rating 22 · As of 2026-11-03
| Price | 2.28 USD |
|---|---|
| 1-day change | -6.6% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 6 / 7 / 70 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 27 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -75.0% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +87.5% |
| Market cap (USD) | $60.2M |